Navigation Links
New High Performance Gas Chromatographs and Analysis Solutions From Varian, Inc. Offer Enhanced Performance and Capabilities for More Applications
Date:3/31/2008

PALO ALTO, Calif., March 31 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) announced today the release of the Varian 400 GC Series, a new family of high performance gas chromatographs and application specific analysis solutions. The 400 Series consists of two gas chromatograph models and an associated range of analyzers and solutions designed for both standard analyses and custom applications. These new systems allow chemists and engineers to employ standard methods and/or high quality trace sample analysis, in the energy, agrochemical and environmental industries.

The Varian 450-GC builds on Varian's longstanding tradition of blending state of the art chromatographic performance with industry leading configuration flexibility. The 450-GC is a powerful and technologically advanced analytical instrument that offers robust operation in an easy-to-use package. The instrument offers users a broad array of inlets and detectors, together with many standard and customizable gas and liquid valve systems. The new, high resolution color touch screen/user interface is intuitive to use, easy to read from a distance and is easily adapted to support local languages. Optional UltiMetal(TM) treatment renders all internal stainless steel components inert to maximize trace sensitivity and deliver improved performance for difficult samples.

The Varian 430-GC offers the same outstanding performance as the 450-GC but in a compact, single channel package that occupies about half the bench space of conventional multi-channel GCs for a safe, less cluttered work environment. It is the perfect alternative for dedicated or routine use.

Gas chromatography is particularly important in a broad range of energy applications including the analysis of petrochemicals, natural gas and biodiesel. Varian has updated its GC analysis solutions to accommodate the latest changes to petrochemical industry standard methods and introduces solutions for biodiesel analysis. B
'/>"/>

SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
2. End-to-End HR Performance Benchmarks: Metrics That Will Help Turn the HR Cost Center into a Productivity Driver
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
5. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
6. North Shore-LIJ Health System Begins Online Posting of Hospital Infection Rates, Other Performance Information
7. QMed, Inc. Extends Agreement & Receives $550,000 Performance Bonus
8. Body-mind meditation boosts performance, reduces stress
9. Halogen Offers Performance Based Integrated Learning Management System
10. Highmarks Hospital Pay-for-Performance Program Demonstrates Impressive Results
11. MED3OOO Client Wins IHA Pay-for-Performance Award
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 3Health News:Wellness Manufacturer Wins Two 2009 American Spa Awards 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 2Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 4Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 5Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 6Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 7Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 8Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 9Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 10Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 11Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5
Breaking Medicine Technology:For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting 2New FDA Approved Breast Cancer Screening Tool 2New FDA Approved Breast Cancer Screening Tool 3Hospital Financials Have Recovered to Pre Recession Levels According to Thomson Reuters Study 60953 1Hospital Financials Have Recovered to Pre Recession Levels According to Thomson Reuters Study 60953 2Hospital Financials Have Recovered to Pre Recession Levels According to Thomson Reuters Study 60953 3Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin 60950 1Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin 60950 2Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 6076 1Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 6076 2Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 6076 3